Business Context and Reporting Period
Company: ACME UNITED CORP (ACU)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: A leading worldwide supplier of first aid, medical products, and cutting/sharpening technology. Operations are segmented geographically into the United States (including Asia), Canada, and Europe. The company sells primarily to mass market retailers, e-commerce platforms, and industrial distributors.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $196.5 million | $194.5 million |
| Gross Profit | $77.4 million (39.4% margin) | $76.4 million (39.3% margin) |
| Operating Income | $14.7 million | $14.1 million |
| Net Income | $10.2 million | $10.0 million |
| Diluted EPS | $2.49 | $2.45 |
| Cash from Operations | $18.2 million | $12.0 million |
| Total Debt Outstanding | $21.8 million | $28.0 million |
| Credit Facility Availability | $53.1 million | $47.3 million (est.) |
| Inventory | $59.9 million | $56.3 million |
Note: Total debt includes $11.9 million under the revolving credit facility and $9.9 million in mortgage payable.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 1% ($2.1 million) driven by strong first aid and medical product sales and an 8% increase in European sales (USD). This offset a 1% decline in U.S. segment sales, attributed to order cancellations in the school/office sector due to tariff uncertainty.
- Profitability: Operating income rose 4% ($0.6 million) due to higher sales volumes and improved gross margins. Net interest expense decreased 20% ($0.4 million) due to lower average borrowings and interest rates.
- Acquisitions:
- Germany (Oct 2025): Acquired cutting/sharpening tools line (Schmiedeglut) for ~$1.6 million; contributed $0.5 million in sales in 2025.
- Elite First Aid (May 2024): Completed acquisition; $0.5 million contingent liability reversed in 2025 as revenue milestones were not met.
- My Medic (Jan 2026): Subsequent event; acquired tactical/trauma product supplier for $18.7 million (closed post-year-end).
- Capital Expenditures: Increased 49% to $10.7 million, primarily for a new 77,000 sq. ft. manufacturing facility in Tennessee for Spill Magic products.
- Dividends: Quarterly dividend increased to $0.16 per share (total annual distribution of $0.63 per share in 2025).
Outlook, Risks, and Management Commentary
- Liquidity: Management maintains a strong liquidity position with $53.1 million available under a $65 million credit facility (maturity extended to May 2027). Cash on hand is $3.6 million.
- Trade and Tariffs: Significant risk exposure to U.S.-China trade relations. While some tariffs were suspended through November 2026, uncertainty remains regarding future trade measures and potential retaliatory duties. The company notes that tariff uncertainty contributed to order cancellations in the school/office market.
- Inflation and Costs: Ongoing inflationary pressure on labor, raw materials, and shipping. The company has invested in robotics and automation to improve productivity and mitigate cost increases.
- Internal Controls: A material weakness in IT General Controls (ITGC) identified in 2024 regarding privileged access management has been remediated as of December 31, 2025. The 2025 audit received an unqualified opinion on internal controls.
- Seasonality: Sales are traditionally stronger in Q2 and Q3 due to the "back-to-school" season for cutting products.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the two customers representing ~13% of consolidated net sales each, and three customers representing ~41% of total trade receivables.
- Tariff Impact: Monitor the resolution of U.S.-China trade negotiations and the potential for renewed tariffs on Asian-sourced products, which could impact the cutting/sharpening segment.
- Acquisition Integration: Assess the integration and revenue contribution of the My Medic acquisition (closed Jan 2026) and the German cutting tools line.
- Inventory Levels: Review inventory turnover (2.1x) and the reserve for slow-moving/obsolete inventory ($1.5 million) given the mix of medical and seasonal school products.
- Debt Covenants: Confirm continued compliance with the revolving credit facility covenants, specifically the funded debt to EBITDA ratio and fixed charge coverage ratio.